Objectives: The aim was to evaluate the effectiveness of topical cyclopentolate following pterygium surgery for post-operative ocular pain. Methods: All participants had nasal pterygium and underwent pterygium excision and conjunctival autografting with fibrin glue. Participants were randomised into two groups. Participants in group 1 received one per cent cyclopentolate eye drops and artificial tears upon completing surgery and were prescribed self-administered drops three times daily for three days, while participants in group 2 received a control (artificial tears) in a manner identical to group 1. Data were gathered regarding post-operative pain intensity experienced during each of the three days. Pain was graded from zero to 10 according to a visual analogue scale, in which zero signified no pain and 10 signified severe, unbearable pain.
A pterygium is a commonly occurring ocular surface disorder, in which a wing-shaped fibrovascular conjunctival growth extends onto the cornea. Conditions that justify surgical intervention include diminished visual acuity, patient discomfort, ocular motility restriction and dysplastic lesions, as well as cosmetic purposes. 1 Surgical excision is the primary method for treating pterygium. Among the treatments, conjunctival autograft with fibrin glue appears to be optimal due to its efficiency and low rates of both surgical complications and recurrence. 2 Nevertheless, the most common postoperative complaint after surgery for pterygium is significant ocular pain. Although various prescribed medications are available to manage post-operative ocular pain and discomfort, patients may still feel pain in variable degrees post-operatively. 3, 4 Novel medications and/or procedures are desired to decrease pain in patients who have undergone pterygium surgery.
Cycloplegic drugs are generally prescribed to relieve the ciliary muscle spasm thought to occur in patients with corneal surface problems, such as corneal abrasions and recurrent erosions. 5 Complete excision of a pterygium from the cornea and sclera, which subsequently leaves a denuded corneoscleral surface, is the main surgical procedure during pterygium surgery. From these findings, we speculated that cycloplegics may be used as an adjunctive treatment to relieve pain following pterygium surgery.
This study aimed to evaluate the effectiveness of topical cyclopentolate after pterygium surgery for the relief of postoperative ocular pain.
METHODS
This study was conducted at the Department of Ophthalmology, Konya Training and Research Hospital, Konya, Turkey. All participants were patients enrolled after having had primary nasal pterygium. Neither systemic analgesic nor topical nonsteroidal anti-inflammatory drops were administered preoperatively. Exclusion criteria included diseases of the immune system, eyelid or ocular surface, history of previous ocular surgery or trauma, collagen vascular disease or diabetes mellitus and hypersensitivity to any component of fibrin glue. If the patients required additional anaesthesia because of significant pain post-operatively, they were excluded from the study.
Participants were given written information detailing the surgical procedure and study. The study received approval from the local ethics committee and was conducted in accordance with the tenets of the Declaration of Helsinki. Informed consent was obtained from all participants.
The area of surgery to be operated upon was sterilised with 10 per cent povidone iodine. After administering a topical 0.5 per cent proparacaine hydrochloride (Alcaine, Alcon, Rotkreuz, Switzerland), an ocular speculum was put into place. Surgery was performed under an operating microscope and subconjunctival anaesthesia was applied using a 27-gauge needle (0.5 ml two per cent lidocaine hydrochloride and adrenaline 0.001 per cent, Jetokaine, Adeka AS, Samsun, Turkey) beneath the body of the pterygium. The head of the pterygium was cut at the limbus and removed from the corneal surface with blunt dissection. Although the cornea can be gently scraped with a blade to ensure the removal of all surface cells, excellent polishing and smoothing of the surface was achieved with a diamond-tipped drill. Minimal cauterisation was applied to control bleeding. A conjunctival graft without Tenon's tissue (superotemporal bulbar conjunctiva) was prepared, excised and spread upon the cornea. The graft was subsequently attached to the bare sclera with fibrin glue. The fibrin glue (Tisseel, TwoComponent Fibrin Sealant Vapor Heated, Baxter Healthcare Corporation, Glendale, California, USA) was prepared according to the manufacturer's directions. The fibrin glue has two components, each of which was drawn out into two separate one mL syringes. One drop of thrombin component was placed on the scleral bed, to which one drop of protein solution was immediately added. The graft was slid over and pressed gently onto the scleral bed. The graft was held in position for up to three minutes, until the fibrin glue was firmly set to prevent tissue displacement. Finally the lid speculum was carefully removed.
The patients were randomised into two groups by a simple randomisation technique. For the members of group 1, one per cent cyclopentolate eye drops (Sikloplejin, Abdi İbrahim, Ankara, Turkey) and artificial tears (Protagent, Liba, Ankara, Turkey) were administered at the end of surgery and prescribed to be selfadministered three times daily for three days after surgery. For the members of group 2, artificial tears were administered in a manner identical to group 1 as controls. Both groups also received topical 0.1 per cent fluorometholone (FML; Allergan, Istanbul, Turkey) and 0.3 per cent ciprofloxacin (Ciloxan, Alcon, Istanbul, Turkey) four times daily after surgery. If the patients became intolerant to pain post-operatively despite the above medication, we planned to offer oral analgesia.
Data were collected regarding the pain experienced at days one, two and three after the operation. Pain was graded from zero to 10 according to a visual analogue scale in which zero signified no pain and 10 signified severe, unbearable pain. A trained examiner recorded the subjective pain scores. Neither the examiner nor the participants knew which participants had received topical cyclopentolate eye drops.
Statistical analysis was performed with SPSS version 15 (SPSS Inc., Chicago, Illinois, USA). Demographic data were compared between the two groups using a Chisquare test. To assess the correlation of the data with normal distribution, the Kolmogorov-Smirnov test was used. For parametric data analyses, Student's t-test was used. Post-operative pain scores in each group were defined as median with interquartile range and were compared with Mann-Whitney U-test. A p-value of less than 0.05 was considered statistically significant.
RESULTS
Group 1 included 38 participants (15 female) and showed a mean age of 39 AE 3.6 years (range 19 to 44 years). Of the 40 members of group 2, 17 were female and the mean age was 37 AE 5.4 years (range 21 to 45 years). Demographic data for both groups are summarised in Table 1 . There were no statistically significant differences in mean age or gender between the two groups (p > 0.05; Table 1 ). The mean extension of the pterygia onto the cornea was 3.02 AE 0.71 mm in group 1 and 2.89 AE 0.50 mm in group 2. The extension of the pterygia did not differ between groups (p = 0.358).
No participants in either treatment group reported a pain score of zero. Median of the pain scores at days one, two and three were as follows, respectively: 4, 2.5 and 2 for group 1 and 5, 3 and 3 for group 2. Pain scores were significantly lower for group 1 compared with group 2 at days one, two and three (p < 0.05). Pain scores are summarised in Table 2 . No local or systemic adverse events resulting from the topical cyclopentolate were observed in group 1.
All of our patients completed the operations with their designated treatment. None of the patients required additional anaesthetic during the post-operative period.
DISCUSSION
Surgery for pterygium causes significant post-operative ocular pain. This pain is likely to originate from both the cornea and conjunctiva. 3, 4 At the same time, managing a post-operative pain regimen remains controversial, although a few studies have mentioned the management of pain after pterygium surgery.
Corneal lesions such as corneal abrasions and recurrent erosions cause pain in the corneal sensory nerve fibres of the affected cornea and pain translates internally. 5 Further, keratitis causes ocular pain, which may be related to ciliary spasm secondary to the corneal neuronal reflex. 6 To relieve ciliary muscle spasms thought to occur in patients with corneal surface problems, cycloplegic drugs are generally prescribed. 5, 6 Cycloplegic drugs do nothing for nerve pain from the cornea but they help reduce the ciliary spasm and make patients a little more comfortable. Complete excision of a pterygium from the cornea and sclera, which subsequently leaves a denuded corneoscleral surface is the chief surgical procedure. On the basis of the aforementioned data, in this study, we have evaluated the effect of topical cyclopentolate as an adjunctive treatment to decrease pain after surgery for pterygium.
This study revealed that pain scores at each recorded time were significantly reduced in the cyclopentolate group compared with the control group. The benefits of treatment were observed at day one and sustained through day three. This is particularly impressive, as no other analgesic agents were used in this study. This study suggests that the use of topical cyclopentolate may be helpful in pain management after pterygium surgery but a properly controlled study with a larger sample is Studies have reported using various medications for post-operative analgesia after pterygium surgery, one of which is viscous lidocaine gel. One particular study concluded that topical lidocaine gel is an effective and safe anaesthetic agent to control the pain experienced shortly after pterygium surgery; 4 however, lidocaine gel could reduce the effectiveness of povidone iodine, which may produce a substantial increase in risk of acute post-operative infection. 7 Topical anaesthetic may cause serious complications, such as delayed wound healing, persistent epithelial defects, corneal ulceration, corneal oedema and keratitis, 8, 9 the last of which surgeons must regularly examine patients post-operatively for early identification. These complications limit the usefulness of topical anaesthetic to control pain after pterygium surgery. Another limitation of this particular study was that its follow-up period (10 hours) was too brief to evaluate the effectiveness of medication for postoperative pain. In contrast, the follow-up period of the present study was three days, which was long enough to reach conclusions.
In another study, orbital morphine was applied as analgesia after pterygium surgery. 3 Orbital morphine was given by peribulbar injection, an invasive procedure that can cause serious complications (for example, optic nerve injury, retrobulbar haemorrhage and globe perforation), 10 thereby reducing this procedure's usefulness.
Topical non-steroidal anti-inflammatory drops have also been used to reduce pain after ocular surgery;
11 however, these drops may cause corneal surface problems, such as slower healing and corneal damage. Additionally, corneal melting, superficial punctate keratitis, corneal infiltrates and epithelial defects have been reported following the administration of topical nonsteroidal anti-inflammatory drops. 12 Cycloplegics are known as anticholinergics that block the action of acetylcholine. In the eye, acetylcholine receptors are located within the iris sphincter muscle as well as in the ciliary body. The activity of these receptors results in the contraction of the iris and ciliary body. Cycloplegics temporarily inhibit this activity, thereby causing ciliary body paralysis and pupillary mydriasis. 13 Cycloplegics can induce acute angleclosure glaucoma as a mydriatic effect of these agents; however, a shallow anterior chamber is a risk factor that should be evaluated before cycloplegia.
14 Although uncommon, cycloplegics may induce mental and neurotoxic effects. 15 We used cyclopentolate in low doses over a brief period and did not observe complications related to the use of cycloplegics.
In conclusion, the results of this study indicate that topical cyclopentolate seems to be effective and well tolerated following surgery for pterygium for post-operative ocular pain. Table 2 . Post-operative pain scores in each group
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